(Q43663481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Helicobacter pylori infectious disease

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

W M Wong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S D Xiao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P J Hu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W H Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Q Gu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Q Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H H-X Xia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S M Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M H Chen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Y Cui

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

K C Lai

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W H C Hu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C K Chan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S K Lam

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

B C-Y Wong

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

73-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15644048%20AND%20SRC:MED&resulttype=core&format=json

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

High prevalence of cagA-positive strains in Helicobacter pylori-infected, healthy, young Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X

13C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02283.X